These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 3159813)
1. [Immunogenicity and safety of hepatitis B virus vaccine (HEPTAVAX-B)]. Kashiwagi S; Hayashi J; Nomura H; Kajiyama W; Ikematsu H; Ohshima M Kansenshogaku Zasshi; 1985 Feb; 59(2):70-6. PubMed ID: 3159813 [No Abstract] [Full Text] [Related]
2. Vaccination against hepatitis B: the Heptavax-B and Recombivax-HB vaccines. Diaz-Arnold AM; Leary JM Dentistry; 1989 Oct; 9(3):21-4. PubMed ID: 2534802 [No Abstract] [Full Text] [Related]
3. Hepatitis B vaccine in pregnancy: immunogenicity, safety and transfer of antibodies to infants. Ayoola EA; Johnson AO Int J Gynaecol Obstet; 1987 Aug; 25(4):297-301. PubMed ID: 2887464 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis B vaccine safety monitoring in the chimpanzee: interpretation of results. Berthelot P; Courouce AM; Eyquem A; Feldmann G; Jacob J; Ravisse P; Vacher B; Moor-Jankowski J; Muchmore E; Prince A J Med Primatol; 1984; 13(3):119-33. PubMed ID: 6239039 [TBL] [Abstract][Full Text] [Related]
5. Hepatitis B vaccination. Fagan EA; Williams R Br J Clin Pract; 1987 Jan; 41(1):569-76. PubMed ID: 2959306 [No Abstract] [Full Text] [Related]
6. Recombinant versus plasma-derived hepatitis B vaccines: issues of safety, immunogenicity and cost-effectiveness. Stephenne J Vaccine; 1988 Aug; 6(4):299-303. PubMed ID: 2973187 [TBL] [Abstract][Full Text] [Related]
7. Safety and immunogenicity of a new heat-inactivated hepatitis B virus vaccine in adult recipients. Chung WK; Sun HS; Chung KW; Kim BS; Min BK; Prince AM Vaccine; 1987 Sep; 5(3):175-8. PubMed ID: 3673203 [TBL] [Abstract][Full Text] [Related]
8. Safety and immunogenicity of a purified hepatitis B virus vaccine prepared by using recombinant DNA technology. Zahradnik JM; Couch RB; Gerin JL J Infect Dis; 1987 May; 155(5):903-8. PubMed ID: 2951449 [TBL] [Abstract][Full Text] [Related]
9. [Immunogenicity and safety of hepatitis B virus vaccine]. Hayashi J; Kashiwagi S; Nomura H; Kajiyama W; Ikematsu H; Aoyama T Kansenshogaku Zasshi; 1985 Oct; 59(10):970-6. PubMed ID: 3936888 [No Abstract] [Full Text] [Related]
10. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates. Gunn TR; Bosley A; Woodfield DG N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527 [TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of low-dose intradermally administered hepatitis B virus vaccine. A cost reduction strategy. Redfield RR; Innis BL; Scott RM; Cannon HG; Bancroft WH JAMA; 1985 Dec; 254(22):3203-6. PubMed ID: 2933535 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis B vaccine associated with erythema nodosum and polyarthritis. Rogerson SJ; Nye FJ BMJ; 1990 Aug; 301(6747):345. PubMed ID: 2144199 [No Abstract] [Full Text] [Related]
14. Should you take the Heptavax-B (hepatitis-B) vaccine? Kulik LT N Y J Dent; 1985; 55(4):133-4. PubMed ID: 3158844 [No Abstract] [Full Text] [Related]
15. Use of Heptavax in Salt Lake County hospitals. Jacobson JT Infect Control; 1985 Jul; 6(7):259-60. PubMed ID: 3159703 [No Abstract] [Full Text] [Related]
16. A randomized double-blind clinical trial of a mammalian cell-derived recombinant DNA hepatitis B vaccine compared with a plasma-derived vaccine. Halliday ML; Rankin JG; Bristow NJ; Coates RA; Corey PN; Strickler AC Arch Intern Med; 1990 Jun; 150(6):1195-200. PubMed ID: 2141247 [TBL] [Abstract][Full Text] [Related]
17. Vasculitis related to hepatitis B vaccine. Cockwell P; Allen MB; Page R BMJ; 1990 Dec; 301(6763):1281. PubMed ID: 2148701 [No Abstract] [Full Text] [Related]
18. Ocular sensitivity to thimerosal: a problem with hepatitis B vaccine? Kirkland LR South Med J; 1990 May; 83(5):497-9. PubMed ID: 2140468 [TBL] [Abstract][Full Text] [Related]
19. So you haven't taken the Heptavax-B vaccine??? Kulik LT N Y J Dent; 1985; 55(6):205-8. PubMed ID: 2931633 [No Abstract] [Full Text] [Related]